150 related articles for article (PubMed ID: 9569080)
1. Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria.
Fu LW; Yang LY; Chen WP; Lin CY
Br J Rheumatol; 1998 Feb; 37(2):217-21. PubMed ID: 9569080
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin pharmacokinetics following administration of capsules and Neoral in paediatric patients with lupus nephritis.
Fu LW; Yang LY; Chen WP; Lin CY
Br J Clin Pharmacol; 1997 Aug; 44(2):125-7. PubMed ID: 9278195
[TBL] [Abstract][Full Text] [Related]
3. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
4. Neoral--new cyclosporin for old?
Somerville MF; Scott DG
Br J Rheumatol; 1997 Oct; 36(10):1113-5. PubMed ID: 9374930
[TBL] [Abstract][Full Text] [Related]
5. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
Zhang M; Qi C; Zha Y; Chen J; Luo P; Wang L; Sun Z; Wan J; Xing C; Wang S; Jiang G; Sun M; Chen Q; Chen J; Li D; Guan T; Ni Z
Clin Rheumatol; 2019 Mar; 38(3):859-867. PubMed ID: 30426311
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
Yumura W; Suganuma S; Uchida K; Moriyama T; Otsubo S; Takei T; Naito M; Koike M; Nitta K; Nihei H
Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
[TBL] [Abstract][Full Text] [Related]
7. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
Dall'Era M; Stone D; Levesque V; Cisternas M; Wofsy D
Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of lupus nephritis with cyclosporin A.
Tam LS; Li EK; Leung CB; Wong KC; Lai FM; Wang A; Szeto CC; Lui SF
QJM; 1998 Aug; 91(8):573-80. PubMed ID: 9893761
[TBL] [Abstract][Full Text] [Related]
9. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis.
Baca V; Catalán T; Villasís-Keever M; Ramón G; Morales AM; Rodríguez-Leyva F
Lupus; 2006; 15(8):490-5. PubMed ID: 16942000
[TBL] [Abstract][Full Text] [Related]
10. Comparative clinical prospective therapeutic study between cyclophosphamide, cyclosporine and azathioprine in the treatment of lupus nephritis.
El-Sehemy MS; Al-Saaran AM; Baddour NM; Adam AG; Moez PE
Egypt J Immunol; 2006; 13(1):39-52. PubMed ID: 17974149
[TBL] [Abstract][Full Text] [Related]
11. Mizoribine for the treatment of lupus nephritis in children and adolescents.
Tanaka H; Tsugawa K; Tsuruga K; Suzuki K; Nakahata T; Ito E; Waga S
Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis.
Ogawa H; Kameda H; Nagasawa H; Sekiguchi N; Takei H; Tsuzaka K; Amano K; Takeuchi T
Mod Rheumatol; 2007; 17(2):92-7. PubMed ID: 17437162
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
14. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A
Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077
[TBL] [Abstract][Full Text] [Related]
15. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade.
Tse KC; Lam MF; Tang SC; Tang CS; Chan TM
Lupus; 2007; 16(1):46-51. PubMed ID: 17283585
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.
Uchino A; Tsukamoto H; Nakashima H; Yoshizawa S; Furugo I; Mitoma H; Oryoji K; Shimoda T; Niiro H; Tada Y; Yano T; Nonaka T; Oishi R; Akashi K; Horiuchi T
Clin Exp Rheumatol; 2010; 28(1):6-12. PubMed ID: 20346231
[TBL] [Abstract][Full Text] [Related]
17. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
Chan TM; Li FK; Wong RW; Wong KL; Chan KW; Cheng IK
Nephron; 1995; 71(3):321-7. PubMed ID: 8569982
[TBL] [Abstract][Full Text] [Related]
18. Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria.
Kasitanon N; Boripatkosol P; Louthrenoo W
Int J Rheum Dis; 2018 Jan; 21(1):200-207. PubMed ID: 28901731
[TBL] [Abstract][Full Text] [Related]
19. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy.
Baqi N; Moazami S; Singh A; Ahmad H; Balachandra S; Tejani A
J Am Soc Nephrol; 1996 Jun; 7(6):924-9. PubMed ID: 8793802
[TBL] [Abstract][Full Text] [Related]
20. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis.
Jesus D; Rodrigues M; da Silva JAP; Inês L
Lupus; 2018 Jul; 27(8):1358-1362. PubMed ID: 29448882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
